Visits: 1493, Avg visit time (secs): 265,71 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 760 | 50,90% | |
| /programmes.html | 131 | 8,77% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-rfa08.html | 61 | 4,09% |
| /amylin/efsd-amylin-rfa08.html | 46 | 3,08% |
| /msd/albert-renold/efsd-msd-arenold.html | 43 | 2,88% |
| /lilly/programme/efsd-lilly-rfa08.html | 39 | 2,61% |
| /pfizer/efsd-pfizer-rfa08.html | 31 | 2,08% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html | 30 | 2,01% |
| /gsk/efsd-gsk-rfa08.html | 22 | 1,47% |
| /lilly/fellowships/efsd-lilly-fship08.html | 19 | 1,27% |
| /efsd-grant/efsd-clinresgrant-rfa07.html | 17 | 1,14% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 836 | 55,99% |
| /pfizer/efsd-pfizer-rfa08.html | 121 | 8,10% |
| /home.html | 49 | 3,28% |
| /lilly/programme/efsd-lilly-rfa08.html | 35 | 2,34% |
| /msd/albert-renold/efsd-msd-arenold.html | 31 | 2,08% |
| /recipients.html | 28 | 1,88% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html | 28 | 1,88% |
| /lilly/programme/efsd-cds-lilly-rfa08.html | 24 | 1,61% |
| /programmes.html | 20 | 1,34% |
| /lilly/fellowships/efsd-lilly-fship08.html | 19 | 1,27% |
| /amylin/efsd-amylin-rfa08.html | 18 | 1,21% |